Key Metrics
CiteScore 

5.9
Eigenfactor 

0.001 - 0.005
H-Index 

57
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Cardiovascular Drugs
American Journal of Cardiovascular Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Cardiovascular Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Cardiovascular Drugs
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
- 9 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.
- 30 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration.
- 25 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Impact of Aspirin on Primary Prevention of Cardiovascular Events in Patients with Elevated Lipoprotein(a): A Systematic Review and Meta-analysis.
- 22 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Transplant Recipients: A Systematic Review and Meta-analyses.
- 20 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Hypertrophic Cardiomyopathy: A Retrospective Cohort Study.
- 16 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
- 9 May 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.
- 30 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration.
- 25 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Impact of Aspirin on Primary Prevention of Cardiovascular Events in Patients with Elevated Lipoprotein(a): A Systematic Review and Meta-analysis.
- 22 Apr 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Transplant Recipients: A Systematic Review and Meta-analyses.
- 20 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Hypertrophic Cardiomyopathy: A Retrospective Cohort Study.
- 16 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions